chr2-227298759-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The NM_000091.5(COL4A3):​c.3829G>A​(p.Gly1277Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000325 in 1,614,042 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G1277G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 2 hom. )

Consequence

COL4A3
NM_000091.5 missense

Scores

13
3
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:7U:13B:3

Conservation

PhyloP100: 7.74

Publications

16 publications found
Variant links:
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
MFF-DT (HGNC:41067): (MFF divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.849
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000091.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
NM_000091.5
MANE Select
c.3829G>Ap.Gly1277Ser
missense
Exon 43 of 52NP_000082.2
MFF-DT
NR_102371.1
n.243+6701C>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
ENST00000396578.8
TSL:1 MANE Select
c.3829G>Ap.Gly1277Ser
missense
Exon 43 of 52ENSP00000379823.3
MFF-DT
ENST00000439598.6
TSL:1
n.243+6701C>T
intron
N/A
COL4A3
ENST00000871618.1
c.3829G>Ap.Gly1277Ser
missense
Exon 43 of 52ENSP00000541677.1

Frequencies

GnomAD3 genomes
AF:
0.000342
AC:
52
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000377
AC:
94
AN:
249374
AF XY:
0.000340
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000513
Gnomad OTH exome
AF:
0.000990
GnomAD4 exome
AF:
0.000323
AC:
472
AN:
1461760
Hom.:
2
Cov.:
31
AF XY:
0.000319
AC XY:
232
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33478
American (AMR)
AF:
0.000962
AC:
43
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53392
Middle Eastern (MID)
AF:
0.00192
AC:
11
AN:
5732
European-Non Finnish (NFE)
AF:
0.000328
AC:
365
AN:
1111964
Other (OTH)
AF:
0.000729
AC:
44
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000341
AC:
52
AN:
152282
Hom.:
0
Cov.:
32
AF XY:
0.000295
AC XY:
22
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41552
American (AMR)
AF:
0.00131
AC:
20
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68016
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000406
Hom.:
0
Bravo
AF:
0.000385
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000243
AC:
2
ExAC
AF:
0.000339
AC:
41
EpiCase
AF:
0.000382
EpiControl
AF:
0.000830

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
5
1
not provided (8)
2
2
-
Alport syndrome (4)
2
1
1
Autosomal dominant Alport syndrome (4)
-
1
1
not specified (2)
-
1
-
Alport syndrome 3b, autosomal recessive (1)
-
1
-
Autosomal recessive Alport syndrome (1)
1
-
-
COL4A3-related disorder (1)
-
1
-
focal and segmental glomerulosclerosis (1)
-
1
-
Hematuria, benign familial, 2;C5882663:Autosomal dominant Alport syndrome;C5882699:Alport syndrome 3b, autosomal recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.58
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Uncertain
0.53
D
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.79
D
MetaRNN
Pathogenic
0.85
D
MetaSVM
Pathogenic
0.86
D
MutationAssessor
Pathogenic
3.6
H
PhyloP100
7.7
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-4.8
D
REVEL
Pathogenic
0.97
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.83
MVP
0.96
MPC
0.19
ClinPred
0.23
T
GERP RS
5.4
Varity_R
0.82
gMVP
0.88
Mutation Taster
=33/67
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs190598500; hg19: chr2-228163475; COSMIC: COSV107359223; COSMIC: COSV107359223; API